California Institute for Regenerative Medicine (CIRM)   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Oakland CA United States (2004)

Organization Overview

First Clinical Trial
2018
NCT03741127
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

California Institute for Regenerative Medicine (CIRM)